How much does arch Therapeutics stock cost?

One share of ARTH stock can currently be purchased for approximately $2.95. How much money does Arch Therapeutics make? Arch Therapeutics (OTCMKTS:ARTH) has a market capitalization of $3.75 million and generates $20,000.00 in revenue each year.

Where is arch Therapeutics Inc headquartered?

The company was founded by Rutledge Ellis-Behnke and Terrence W. Norchi on September 16, 2009 and is headquartered in Framingham, MA. ARTH | Complete Arch Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

What does arch Therapeutics do?

Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. The company develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease.